Technology Review Committee

In addition to a board of directors, MedBlue Incubator has a Technology Review Committee, chaired by Bud Nelson and is comprised of representatives from each of the member departments at Duke University, a representative from the Duke Office of Translation and Commercialization, MedBlue management, and strategically invited third parties.

The role of the Technology Review Committee is to review innovative medical technology and IP from entrepreneurs in the member departments (and potentially other departments within the Duke University community) that are identified through proposal submission process. Following a Based on its review, the Committee selects the most promising opportunities for participation in the MedBlue Incubator program and makes recommendations for funding to the MedBlue Board of directors.

The current members of the MedBlue Technology Review Committee are:

  • Bud Nelson PhD JD Chairman – MedBlue Incubator

  • Aravind Asokan PhD – Professor in Surgery, Director of Gene Therapy, Professor of Molecular Genetics and Microbiology, Professor of Biomedical Engineering, Affiliate of the Duke Regeneration Center - Department of Surgery-Division of Surgical Sciences

  • Jee Jung MBA MAC – Assistant Director of Duke New Ventures - Office of Translation and Commercialization, New Ventures

  • Vijay Krishnamoorthy MD PhD – Associate Professor of Anesthesiology, Associate Professor of Population Health Sciences - Department of Anesthesiology, Critical Care Medicine Division

  • Teilo Schaller PhD PMP – Senior Associate - Alexandria Venture Investments

  • Mike Moverman MD, MMS – Assistant Professor of Orthopaedic Surgery - Department of Orthopaedics, Division of Sports Medicine

  • Darin Dufault MD – Associate Professor of Medicine, Director of Third Space Endoscopy - Department of Medicine, Division of Gastroenterology

  • Nandan Lad MD PhD – Professor of Neurosurgery, Vice Chair of Innovation - Department of Neurosurgery

  • Jadee Neff MD PhD – Assistant Professor of Pathology, Member Duke Cancer Institute - Department of Pathology, Clinical Services

  • Emily Song - Duke University

  • Blake Long MD MBA – MedBlue Incubator